跳至主要内容
临床试验/NCT00764049
NCT00764049已完成1 期

Prospective Pilot Study Assessing Safety and Efficacy of Single Pass Albumin Dialysis in Patients With Acute on Chronic Liver Failure

Assistance Publique - Hôpitaux de Paris2 个研究点 分布在 1 个国家目标入组 11 人开始时间: 2009年6月最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
入组人数
11
试验地点
2
主要终点
Effects on clinical and biochemical variables

研究概览

简要总结

The aim of this study is to determine whether a simplified device of albumin dialysis also has beneficial effects.

详细描述

Albumin dialysis has beneficial effects in patients with acute on chronic liver failure. However, current devices are complex and costly. The aim of this study is to determine whether a simplified device of albumin dialysis also has beneficial effects.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Minimum age of 18 years
  • Written consent after information of the patient or, in case of inability, by a parent or a close if he is present.
  • Patient having a cirrhosis researched by previous exams (liver biopsy) or, in the absence of previous diagnosis, diagnosed in view of the results of clinical, biological and morphological data, whatever the origin of the cirrhosis (virus of hepatitis B, virus of hepatitis C, extreme consumption of alcohol or other reasons)

排除标准

  • Participation to an other study in the 4 weeks before
  • Active digestive bleeding, unchecked by the pharmacological treatments and the endoscopic techniques.

结局指标

主要结局

Effects on clinical and biochemical variables

时间窗: 3 months follow-up

次要结局

  • Safety(3 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验